Navigation Links
Cellceutix CEO, Leo Ehrlich, Conducts Interview with "Biotech Stock Trader"; Dr. Paul Ginsberg, (Renowned Patent Attorney) Joins Cellceutix Advisory Board
Date:4/18/2011

r. Ginsburg has authored the patent application for Cellceutix anticancer product Kevetrin™, which has been filed in the United States and other countries and has advised Cellceutix on patent and licensing matters during the past few years.

About Cellceutix

Cellceutix Corporation is a preclinical cancer, anti-inflammatory and autism drug developer. Cellceutix owns the rights to eight drug compounds, including Kevetrin, which it is developing as a treatment for certain cancers, KM-133, for the treatment of psoriasis, and KM-391, for the treatment of autism. More information is available on the Cellceutix web site at www.cellceutix.com.

This Press Release contains forward-looking statements that are based on our current expectations, beliefs and assumptions about the industry and markets in which Cellceutix Corporation operates. Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause Cellceutix's actual results to be materially different from any future results expressed or implied by these statements. Actual results may differ materially from what is expressed in these statements, and no assurance can be given that Cellceutix can successfully implement its core business strategy and improve future earnings.

The factors that may cause Cellceutix's actual results to differ from its forward-looking statements include: Cellceutix's current critical need for additional cash to sustain existing operations and meet ongoing existing obligations and capital requirements; Cellceutix's ability to implement its new product development and commercialization, enter into clinical trials, expand the intellectual property portfolio, and receive regulatory approvals in a timely and cost-effective manner. All forward-looking statements are also expressly qualified in their entirety by the cautionary statements inclu
'/>"/>

SOURCE Cellceutix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cellceutix Poster Presentation on its p53 Cancer Breakthrough Attracts Wide Interest at 102nd AACR Meeting
2. Cellceutix Reports Production of Its Anti-Cancer Drug Kevetrin™ Has Begun
3. Cellceutix Reports Confidential Disclosure Agreement Signed With Major Pharmaceutical Company
4. Cellceutix Discovers Drug Activates Guardian Angel p53 in Fight Against Leukemia
5. Cellceutix Cancer Drug Kevetrin™ Shows No Genotoxicity in Study
6. Sonic Innovations Conducts National Training Events for Government Clinicians
7. Impliant Conducts the First Two Implantations of Its New TOPS VersaLink Spinal System
8. Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
9. Maine Natural Health Company Conducts Dental Clinical Trial
10. OXIS International Executives Interviewed on StockGoodies.com Radio
11. Cardiogenesis Executive Chairman Paul J. McCormick Updates Commercial and Regulatory Progress in Interview With Wall Street Reporter, Available Online
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... NEWARK, N.J. , Aug. 27, 2015  Symbiomix ... Phase 3 clinical study, the second pivotal trial of ... the treatment of bacterial vaginosis (BV). Earlier this year ... for SYM-1219. Symbiomix expects to finish this second pivotal ... a New Drug Application (NDA) filing with the U.S. ...
(Date:8/27/2015)... -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN ) today announced that ... a corporate overview and business update at two investor conferences ... . , 22 nd Annual NewsMakers in ... Millennium Broadway Hotel. , Rodman & Renshaw Annual Global ... Regis Hotel. To access the live audio webcast ...
(Date:8/26/2015)... PUNE, India , August 27, 2015 ... market research reports reviewing the genotyping technology, ... as well as single nucleotide polymorphism (SNP) ... ReportsnReports.com. Complete report on genotyping ... spread across 200 pages, profiling 10 major ...
Breaking Medicine Technology:Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 2Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 3Symbiomix Therapeutics Completes Enrollment in Second Pivotal Trial of SYM-1219 for Bacterial Vaginosis, and Receives FDA Fast Track Designation 4SciClone To Present At Two Investor Conferences On September 10, 2015 2Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 2Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 3Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 4Genotyping Market Forecast to Grow at 22.3% CAGR to 2020 5
... The law firm of Childers, Schlueter & Smith, LLC of ... will be held during the week of July 26, 2010 .  The ... States District Court, Northern District of Georgia , Atlanta Division. , ... The lawsuit alleges that the drug makers and ...
... Inc. (NYSE Amex: MHH ) ("Mastech"), a national provider of Information Technology ... discuss the results of its second quarter ended June 30, 2010 . ... 9:00 a.m. Eastern Time and will be hosted by Mr. ... , , ...
Cached Medicine Technology:Childers, Schlueter & Smith, LLC Set for Reglan/metoclopramide Jury Trial Involving Woman's Development of Tardive Dyskinesia 2Mastech Holdings, Inc. to Discuss Second Quarter 2010 Financial Results on July 28, 2010 2
(Date:8/27/2015)... ... August 27, 2015 , ... ... scheduled for October 27-29, 2015 in San Jose, CA. The first event ... focus on the void that exists where battery development and energy storage innovation ...
(Date:8/27/2015)... ... August 27, 2015 , ... In addition to its existing Doctor ... a third doctoral program at its main campus in Reading: Doctor of Nursing Practice. ... designed to prepare advanced practice nurses for the highest level of clinical nursing practice. ...
(Date:8/27/2015)... ... ... Pinellas, located at 1395 South Pinellas Avenue in Tarpon Springs, will open a free-standing emergency ... at US Highway 19 North and Highlands Boulevard, less than eight miles from the main ... is slated to begin in September 2015. , The new 24-bed facility will ...
(Date:8/27/2015)... (PRWEB) , ... August 27, 2015 , ... NetDimensions ... , “The companies selected have the platforms required not only to effectively deliver, curate ... Taylor, President of Training Industry, Inc. , For six consecutive years, NetDimensions has ...
(Date:8/27/2015)... ... August 27, 2015 , ... ... they have launched their new corporate website http://www.Z-Medica.com , to further support ... website that was launched last year. , “We launched a branded website ...
Breaking Medicine News(10 mins):Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 2Health News:NetDimensions Named Among Top 20 Learning Portal Companies of 2015 3Health News:Z-Medica® Launches New Corporate Website 2
... Heavy alcohol consumption, specifically three or more glasses of ... of death from pancreatic cancer, according to a report ... Internal Medicine, one of the JAMA/Archives journals. ... is causally related to several cancers, including oral cavity, ...
... , , , , ... AUDIO: Washington University,s Victoria Fraser, MD, talks about ... , , , , ... , , , , , , ...
... March 14 (HealthDay News) -- A lack of vitamin ... but levels of the vitamin don,t decrease as the ... insufficiency has been associated with a variety of clinical ... strength, mood and cognitive dysfunction, autoimmune disorders such as ...
... HealthDay Reporter , MONDAY, March 14 (HealthDay News) -- Women ... fatty acids found in that meal choice -- have a ... suggests. This latest evidence of a protective link between ... found the same benefit. In this study, Harvard researchers performed ...
... March 14, 2011 -- Some physicians are prescribing opioids such ... a new study led by St. Michael,s Hospital and the ... opioid-related deaths occur among patients treated by physicians who frequently ... may not be doing so safely. "We found that ...
... technique called microdissection testicular sperm extraction (TESE) can effectively ... of adult male childhood cancer survivors who were previously ... result, many of the men were subsequently able to ... The findings offer a new option for many cancer ...
Cached Medicine News:Health News:Heavy drinking associated with increased risk of death from pancreatic cancer 2Health News:Novel strategies target health care-associated infections 2Health News:Novel strategies target health care-associated infections 3Health News:Novel strategies target health care-associated infections 4Health News:Study: Lack of Vitamin D May Precede Onset of Parkinson's 2Health News:Eating Fish Might Protect Your Eyesight 2Health News:Eating Fish Might Protect Your Eyesight 3Health News:Painkiller prescribing varies dramatically among family physicians: study 2Health News:Surgical technique helps adult male survivors of childhood cancer regain fertility 2Health News:Surgical technique helps adult male survivors of childhood cancer regain fertility 3
... (IGF-I or somatomedin C) is a 7.6 kDa ... as a potent mitogen of cellular proliferation, exerting ... In the circulation, IGF-I is bound to IGF-binding ... of IGF-I by modulating the interaction of IGF-I ...
Inquire...
... table comes in two modelsthe BT4, which ... BT5, which offers five. With the simple ... to suit your needs. Both models ... side rails, ankle/foot supports, adjustable arm boards, ...
... A revolutionary urological imaging system ... that translate into improved patient ... 1k imaging technology physicians and ... see more anatomical detail and ...
Medicine Products: